BioNeutra Global (TSXV:BGA) Accounts Payable & Accrued Expense : C$14.98 Mil (As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is BioNeutra Global Accounts Payable & Accrued Expense?

BioNeutra Global's quarterly accounts payable & accrued expense declined from Sep. 2023 (C$15.04 Mil) to Dec. 2023 (C$13.57 Mil) but then increased from Dec. 2023 (C$13.57 Mil) to Mar. 2024 (C$14.98 Mil).

BioNeutra Global's annual accounts payable & accrued expense increased from Dec. 2021 (C$14.80 Mil) to Dec. 2022 (C$16.07 Mil) but then declined from Dec. 2022 (C$16.07 Mil) to Dec. 2023 (C$13.57 Mil).

BioNeutra Global Accounts Payable & Accrued Expense Historical Data

The historical data trend for BioNeutra Global's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNeutra Global Accounts Payable & Accrued Expense Chart

BioNeutra Global Annual Data

Trend

Feb14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

20.94

15.43

14.80

16.07

13.57

BioNeutra Global Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															15.24	14.78	15.04	13.57	14.98

BioNeutra Global Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

BioNeutra Global (TSXV:BGA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioNeutra Global Corp (TSXV:BGA) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

BGACF:USA

Address

9608 - 25 Avenue NW, Edmonton, AB, CAN, T6N 1J4

Website

http://www.bioneutra.ca

BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.

Executives

Monica Barclay

Senior Officer

BioNeutra Global (TSXV:BGA) Headlines

No Headlines